Oppenheimer raised the firm’s price target on Pennant Group (PNTG) to $40 from $37 and keeps an Outperform rating on the shares following the company’s earnings reported. The firm argues that the strong results reflect the continued integration of the AMED/UNH deal, which is on-track to be completed by the end of Q3 2026. While the results were solid, Pennant is holding off on updating guidance until it sees one more quarter. With that said, management is now pointing toward the top-end of its prior 2026 guidance ranges, adds Oppenheimer.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PNTG:
- Pennant Group balances rapid growth with integration risk
- Pennant Group reports Q1 adjusted EPS 32c, consensus 31c
- Pennant Group Posts Strong First-Quarter 2026 Revenue Growth
- Pennant Group acquires three senior living communities in Arizona, Wisconsin
- Pennant Group price target raised to $36 from $34 at Truist
